Hologic Inc (LTS:0J5Q)
$ 78.11 -1.51 (-1.9%) Market Cap: 17.93 Bil Enterprise Value: 18.25 Bil PE Ratio: 23.87 PB Ratio: 3.59 GF Score: 85/100

Hologic Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 09:40PM GMT
Release Date Price: $46.31
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst

We can look to get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Steve MacMillan from Hologic, CEO, with us. There's 35-minute sessions, certainly open to questions. If you have any, just feel free to raise your hand. We'll try to look through the lights here.

But Steve, I think you wanted to just open with a few comments, then we can dive into Q&A.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Sure, Patrick. First off, thanks for having us. Great to see you.

I think at the highest level, as you look at the company today, what we feel really good about is -- and I'd say it's kind of for the first time certainly in my tenure in 5.5 years, whatever, where we have our largest businesses going in a great trajectory as well as both U.S. and internationally. So said simply, we've got our Breast Health business doing well in the U.S. and internationally. We have our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot